|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$81,660,525 |
|
|
Indirect Value
|
$12,932,114,466 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,013,774,992 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 37 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-01-03 |
4 |
S |
$13.29 |
$137,270 |
I/I |
(10,327) |
946,631 |
0 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2005-07-14 |
4 |
B |
$3.50 |
$138,306 |
I/I |
39,516 |
435,854 |
1.5 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2010-05-07 |
4 |
S |
$12.46 |
$138,338 |
I/I |
(11,104) |
301,337 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-07-25 |
4 |
S |
$15.01 |
$138,468 |
I/I |
(9,224) |
221,901 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2010-08-09 |
4 |
S |
$14.08 |
$139,654 |
I/I |
(9,916) |
272,438 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-08 |
4 |
B |
$26.17 |
$139,904 |
I/I |
5,340 |
197,404 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2006-08-11 |
4 |
B |
$4.03 |
$139,991 |
I/I |
34,745 |
1,523,919 |
2.25 |
- |
|
INCY |
Incyte Corp |
Director |
|
2010-08-09 |
4 |
S |
$14.08 |
$140,710 |
I/I |
(9,991) |
274,458 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-01-04 |
4 |
S |
$13.14 |
$141,379 |
I/I |
(10,757) |
935,874 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2009-05-20 |
4 |
B |
$9.72 |
$141,679 |
I/I |
14,576 |
171,479 |
2.25 |
- |
|
INCY |
Incyte Corp |
Director |
|
2012-01-12 |
4 |
B |
$16.21 |
$142,615 |
I/I |
8,769 |
349,983 |
2.25 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-10-31 |
4 |
S |
$11.70 |
$142,662 |
I/I |
(12,198) |
653,129 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-03-18 |
4 |
B |
$8.02 |
$142,732 |
I/I |
17,793 |
3,974,756 |
2.25 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-07-01 |
4 |
S |
$14.51 |
$142,740 |
I/I |
(9,835) |
566,474 |
0 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2004-03-15 |
4 |
B |
$16.11 |
$143,040 |
I/I |
8,877 |
208,142 |
1.5 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2011-08-24 |
4 |
B |
$14.98 |
$143,432 |
I/I |
9,576 |
13,662,043 |
2.25 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2007-06-19 |
4 |
S |
$5.64 |
$143,750 |
I/I |
(25,265) |
203,150 |
0 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-01-15 |
4 |
B |
$7.50 |
$145,005 |
I/I |
19,334 |
6,489,444 |
1.5 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-16 |
4 |
B |
$28.96 |
$145,350 |
I/I |
4,889 |
210,320 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-21 |
4 |
B |
$27.98 |
$145,955 |
I/I |
5,217 |
1,411,266 |
2.25 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-07-23 |
4 |
S |
$14.86 |
$146,198 |
I/I |
(9,839) |
246,499 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-11-07 |
4 |
B |
$26.20 |
$146,550 |
I/I |
5,584 |
170,506 |
2.25 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2008-04-17 |
4 |
B |
$13.28 |
$146,664 |
I/I |
11,044 |
1,167,560 |
1.5 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-07-29 |
4 |
S |
$14.93 |
$146,906 |
I/I |
(9,839) |
209,110 |
0 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2007-04-13 |
4 |
S |
$15.30 |
$147,728 |
I/I |
(9,650) |
101,189 |
0 |
- |
|
1397 Records found
|
|
Page 37 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|